Affective Neuroscience: An Introduction | w4dey

I. Introduction

Emotions are an integral part of human experience, shaping our thoughts, behaviours, and relationships. The study of emotions has traditionally been the domain of psychology, with theories and models focused on subjective experiences and observable behaviours. However, with advances in neuroimaging and neurophysiology, there has been a growing interest in the neural mechanisms underlying emotions. This interest has led to the development of a field of study known as affective neuroscience, which seeks to understand the neurobiological and neuropsychological bases of emotions and their role in affective behaviours.

Affective neuroscience is an interdisciplinary field that draws on insights from neuroscience, neuropsychology, ethology, psychiatry, and psychotherapy. It explores the neural circuits, brain regions, and neurotransmitters involved in emotion processing and emotional regulation, as well as the affective, cognitive and behavioural consequences of emotional states. Through this interdisciplinary approach, affective neuroscience provides far-reaching insight into the nature of emotions and their relevance to mental health, well-being and the everyday life.

This article will provide a sketch of affective neuroscience limited to its main concepts and clinical applications. The article will explore the neurobiological and neuropsychological bases of emotions, the processes involved in emotion regulation and dysregulation, and the ways in which affective neuroscience has informed psychotherapy and clinical interventions for emotional disorders. The implications of this research for current and future research and clinical practice will be touched upon briefly.

Affective neuroscience is an interdisciplinary field that seeks to understand the neurobiological basis of emotions and their role in behaviour. At its core, affective neuroscience explores the neural circuits, brain regions, and neurotransmitters involved in emotion processing and regulation and the cognitive and behavioural consequences of emotional states. This field provides an integrative perspective on how the brain generates emotions and how emotions, in turn, influence various aspects of human experience, such as decision-making, social interaction, and mental health.

Affective neuroscience has been instrumental in expanding our understanding of the neural basis of emotional processing and regulation, highlighting the importance of brain regions such as the amygdala, insula, and prefrontal cortex. By studying the neural correlates of emotions and their regulation, researchers have gained new insights into emotions’ complexity and adaptive functions. This study has implications for various fields, including psychology, psychiatry, and neuroscience, as well as for the development of new interventions for emotional disorders.

Mark Solms and Jaak Panksepp are two prominent figures in the field of affective neuroscience who have made significant contributions to our understanding of emotions and their neural basis. While they have different areas of focus, their work complements each other in substantive ways.

Solms’ work on the role of the brainstem in emotional processing and the generation of conscious experience has provided a foundation for understanding the biological basis of emotions. In contrast, Panksepp’s work on the emotional systems of the brain has identified specific neural circuits that underlie different emotions and affective states.

By combining Solms’ and Panksepp’s findings, researchers and clinicians can gain a more complete understanding of the neural mechanisms underlying emotions and their role in mental health disorders. For example, Panksepp’s work on the neural basis of separation distress complements Solms’ ideas on the role of the brainstem in regulating attachment behaviours.

The work of Solms and Panksepp provide complementary insights into the neurobiological basis of emotions, highlighting the importance of a multidisciplinary approach to understanding and treating mental health disorders.

Overall, affective neuroscience is a growing field that offers a unique perspective on the nature of emotions and their relevance to human behaviour and well-being. By combining insights from neuroscience, psychology, and psychiatry, this field has the potential to transform our understanding of emotions and their role in shaping our lives.

Emotions are fundamental to human experience and play a critical role in shaping our thoughts, behaviours, and social interactions. They are complex psychological states characterised by subjective feelings, physiological changes, and behavioural responses triggered by various internal and external stimuli.

Emotions serve essential adaptive functions, helping us to respond effectively to our environment and to communicate our needs and intentions to others. For example, fear helps us to avoid danger, while joy enhances social bonding and fosters exploration. Emotions also influence our cognitive processes, such as attention, memory, and decision-making, and can impact our physical health.

However, emotions can also become dysregulated, leading to mental health problems such as anxiety, depression, and post-traumatic stress disorder (PTSD). In some cases, people may struggle to regulate their emotions, experiencing intense or prolonged emotional states that interfere with their daily functioning. In other cases, people may avoid or suppress their emotions, leading to psychological and physiological problems.

The study of emotions and their regulation has important implications for mental health. Researchers have developed new interventions to treat emotional disorders, such as mentalisation-based therapy (MBT) and mindfulness-based therapies, by understanding the neural and cognitive mechanisms underlying emotional processing and regulation. These approaches aim to help individuals develop effective emotion regulation strategies and change maladaptive thinking and behaviour patterns.

Emotions are essential to human experience and profoundly affect mental health. By studying the nature of emotions and their regulation, researchers can develop new interventions (i.e., neurological and psychological) to help individuals cope with emotional difficulties and improve their overall well-being.

Affective neuroscience is a field of study that has emerged from the intersection of neuroscience and psychology, intending to understand the neural mechanisms underlying emotions and their role in behaviour. The field has a rich history, spanning several centuries, and has undergone significant transformations with technological advances and new theoretical perspectives.

The earliest theories of emotions date back to the ancient Greeks, who believed disturbances in bodily fluids caused emotions. In the 19th century, the idea that emotions were associated with specific brain regions gained traction with the work of neurologists, Paul Broca and Carl Wernicke and Sigmund Freud. In the early 20th century, pioneers such as Walter Cannon and William James proposed the “fight or flight” response as a universal pattern of physiological arousal in response to emotional stimuli.

Affective neuroscience began to take shape in the mid-20th century with pioneers such as Paul MacLean and Jaak Panksepp, who proposed that emotions were mediated by evolutionarily ancient brain structures such as the limbic system. Subsequently, technological advances in neuroimaging and electrophysiology have allowed for a more detailed understanding of the neural mechanisms underlying emotional processing.

Fundamental concepts in affective neuroscience include:

• the distinction between affective states (i.e., transient emotional experiences) and traits (i.e., stable individual differences in emotional reactivity),
• the role of cognitive processes in modulating emotional responses, and
• the role of non-conscious processes, biography and relational factors in shaping emotional experiences.

Theoretical frameworks from other disciplines, such as the attachment theory of John Bowlby, the mentalisation-based therapy (MBT) of Anthony Bateman & Peter Fonagy, and the polyvagal theory of Stephen Porges, have each significantly influenced the field.

Affective neuroscience is a rapidly evolving field that seeks to understand the neural mechanisms underlying emotions and their role in behaviour. Its historical development has been characterised by a continuous interaction between theoretical frameworks and technological advances, resulting in an increasingly sophisticated understanding of the complex interplay between the brain and behaviour.

II. Neurobiological Basis of Emotion

Emotions are complex phenomena that involve the coordinated activation of multiple brain regions and neural circuits. Several brain structures have been identified as playing a critical role in processing emotional information, including the amygdala, prefrontal cortex, hippocampus, and ventral striatum.

The amygdala is perhaps the most well-known of these structures and is widely recognised as a vital component of the brain’s emotional processing network. The amygdala is involved in rapidly detecting potential threats in the environment and is also implicated in forming emotional memories.

The prefrontal cortex is another brain region critically involved in emotional processing. Specifically, the ventromedial prefrontal cortex (vmPFC) has been implicated in the regulation of emotional responses and in decision-making processes that involve weighing the costs and benefits of different outcomes.

The hippocampus is another brain structure known to be involved in emotional processing. Specifically, the hippocampus forms long-term memories, including memories of emotionally salient events.

Finally, the ventral striatum has also been implicated in emotional processing, particularly reward processing. The ventral striatum is involved in processing information related to reward and motivation and is thought to play a vital role in driving goal-directed behaviour.

The neural circuits underlying emotional processing involve complex interactions between these and other brain regions. For example, the amygdala is known to communicate with the prefrontal cortex and the hippocampus, with these interactions playing a critical role in regulating emotional responses and forming emotional memories. Similarly, the ventral striatum is thought to interact with the prefrontal cortex and other brain regions to integrate information about the motivational significance of stimuli and to guide behaviour accordingly.

The amygdala, prefrontal cortex, hippocampus, and ventral striatum are all critical components of the brain’s emotional processing network, with each structure playing a distinct but interrelated role in processing emotional information. The neural circuits underlying emotional processing are complex and involve interactions between multiple brain regions, with the precise nature of these interactions continuing to be the subject of ongoing research.

Neurotransmitters play a crucial role in regulating emotions and mood. Dopamine, serotonin, and norepinephrine are three neurotransmitters that are particularly important in this regard.

Dopamine is often associated with feelings of pleasure and reward and is involved in processing positive emotions such as joy and excitement. It is produced in the brain’s ventral tegmental area (VTA) and released in various regions, including the prefrontal cortex and the nucleus accumbens, part of the ventral striatum. However, imbalances in dopamine levels can lead to mood disorders such as depression and bipolar disorder.

Serotonin is another significant neurotransmitter involved in regulating emotions. It is produced in the raphe nuclei of the brainstem and is involved in processing various emotions, including happiness, sadness, and anxiety. Imbalances in serotonin levels are associated with mood disorders such as depression, anxiety, and obsessive-compulsive disorder.

Norepinephrine is a neurotransmitter involved in the body’s adrenal (“fight or flight”) response to stress. It is produced in the locus coeruleus in the brainstem and regulates arousal and attention. Imbalances in norepinephrine levels are associated with mood disorders such as anxiety and depression.

Neurotransmitters play a crucial role in regulating emotions and mood, and their levels’ imbalances can contribute to mood disorders’ development. Understanding the role of neurotransmitters in emotion regulation can inform the development of treatments for mood disorders that target these neural systems.

Emotional responses are complex phenomena that involve a range of neurophysiological processes, including the autonomic nervous system (ANS) and hormonal pathways.

The ANS regulates non-conscious bodily functions like heart rate, breathing, and digestion. It is divided into two branches: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS). The SNS is activated in response to stress or danger and triggers the “fight or flight” response, increasing heart rate, blood pressure, and respiration, while the PNS promotes relaxation and digestion. These responses are closely linked to emotional experiences, and changes in ANS activity can be used to assess emotional responses.

Hormonal pathways also play a significant role in emotional responses. The hypothalamic-pituitary-adrenal (HPA) axis is a critical hormonal pathway involved in the stress response. In response to stress, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to release cortisol, a stress hormone. This pathway regulates physiological responses to stress and is implicated in the development of mood disorders such as depression and anxiety.

Other hormonal pathways, such as oxytocin and vasopressin, are involved in social bonding and attachment. Oxytocin, for example, has been shown to increase trust, empathy, and social affiliation, while vasopressin is involved in aggression and territorial behaviour.

Emotional responses involve complex interactions between neural, autonomic, and hormonal processes. Understanding the neurophysiological mechanisms underlying emotional responses can provide insight into the development of mood disorders and inform the development of treatments targeting these processes.

III. Emotion Regulation and Dysregulation

Emotion regulation refers to the processes that allow individuals to modulate their emotional experiences and expressions. The ability to regulate emotions effectively is crucial for psychological well-being, as poor emotion regulation has been linked to the development of various mental health disorders such as anxiety and depression. Affective neuroscience has significantly contributed to understanding the neural mechanisms and processes involved in emotion regulation.

One crucial emotion regulation process is cognitive reappraisal, which involves reinterpreting the meaning of a stimulus in a way that alters its emotional impact. This process is associated with activation in the prefrontal cortex, especially the ventrolateral prefrontal cortex, which has been implicated in cognitive control and emotion regulation. Additionally, research has demonstrated that cognitive reappraisal can modulate activity in the amygdala, which is involved in processing emotional stimuli.

Another emotion regulation process is emotional suppression, which involves inhibiting or reducing the expression of an emotional response. However, research has shown that emotional suppression can lead to increased physiological arousal and negative affect, potentially leading to the development of mental health disturbances. The neural mechanisms underlying emotional suppression are not well understood, but it has been suggested that it involves activation of the prefrontal cortex and the limbic system.

Recent research has also identified several brain regions and networks involved in emotion regulation, including the default mode network (DMN), the salience network, and the central executive network (CEN). The DMN is active during introspection and mind-wandering, and its deactivation is associated with cognitive tasks that require attention and cognitive control. The salience network monitors and filters salient information, while the CEN is associated with working memory and cognitive control. The interaction between these networks is thought to play a critical role in emotion regulation.

Emotion regulation is a complex process involving various brain regions and networks. Understanding the neural mechanisms and processes underlying emotion regulation can provide insights into developing and treating mental health disorders.

Jaak Panksepp was an Estonian pioneer in the field of affective neuroscience who made significant contributions to our understanding of the neural mechanisms underlying emotions and their role in behaviour. Panksepp believed that emotional dysregulation, particularly in the early stages of development, could contribute to the development of various mental health disorders, including anxiety, depression, and borderline personality disorder.

Panksepp’s research focused on the role of subcortical brain structures, particularly the amygdala and the prefrontal cortex, in regulating emotional responses. He identified several subcortical neural circuits involved in regulating emotions, including the SEEKING, RAGE, and FEAR systems. According to Panksepp, imbalances in these systems, particularly during critical periods of development, can lead to emotional dysregulation and the development of various mental health disorders.

For example, Panksepp proposed that a deficit in the SEEKING system, which is responsible for motivation and reward-seeking behaviour, could contribute to the development of depression. He suggested that individuals with depression may have a reduced capacity for pleasure and reward-seeking behaviour, which could be related to dysfunctions in the SEEKING system.

Similarly, Panksepp proposed that dysregulation of the FEAR system, which is involved in regulating anxiety and fear responses, could contribute to the development of anxiety disorders. He suggested that chronic activation of the FEAR system could lead to hyperarousal and hypervigilance, common features of anxiety disorders.

In the specific case of borderline personality disorder (BPD), Panksepp suggested that dysregulation of the social and attachment systems could contribute to the development of the condition. He proposed that individuals with BPD may have a heightened sensitivity to social cues, particularly those related to rejection and abandonment, which could lead to emotional dysregulation and instability.

Panksepp’s work highlights the importance of emotional regulation in mental health and the potential consequences of emotional dysregulation during critical periods of development. His research has important implications for the development of interventions that target emotional dysregulation and related mental health disorders.

Environmental factors, early life experiences, trauma, and genetics shape emotion regulation abilities and vulnerabilities to mental health disorders.

Research has shown that genetic factors play a role in developing emotion regulation abilities and vulnerability to mental health disorders. For example, studies have identified genetic variations associated with emotional processing and regulation, such as the serotonin transporter gene (5-HTT) and the catechol-O-methyltransferase gene (COMT).

However, environmental factors, particularly early life experiences, are crucial in shaping emotion regulation abilities and vulnerability to mental health disorders. Adverse childhood experiences, such as abuse, neglect, and parental conflict, can disrupt the development of emotion regulation abilities and increase the risk for mental health disorders later in life. For example, studies have shown that individuals who experienced childhood maltreatment are more likely to develop depression, anxiety, and borderline personality disorder.

Trauma in childhood and adulthood can also significantly impact emotion regulation abilities and vulnerability to mental health disorders. Trauma exposure can lead to emotional regulation difficulties, including hyperarousal, avoidance, and emotional numbing. These difficulties can contribute to the development of post-traumatic stress disorder (PTSD) and other mental health disorders.

Furthermore, research has demonstrated that the interplay between genetic and environmental factors can influence the development of emotion regulation abilities and vulnerability to mental health disorders. For example, individuals with a genetic susceptibility to depression may be more likely to develop the condition if they experience adverse life events, such as loss or trauma.

A complex interplay of environmental factors and genetics shapes emotion regulation abilities and vulnerability to mental health disorders. Early life experiences, trauma, and genetic variations can all contribute to developing emotion regulation difficulties and increase the risk for mental health disorders. 

Understanding these factors can inform the development of targeted interventions to improve emotion regulation abilities and prevent the development of mental health disorders.

Notably, Panksepp’s work in affective neuroscience has illuminated the critical role of early life experiences, trauma, and genetics in shaping emotion regulation abilities and vulnerabilities to mental health disorders. Panksepp’s research on animal models (affective ethology) has shown that early social experiences can have a lasting impact on brain development and emotional functioning, with disruptions in early attachment and social bonding increasing the risk for emotional dysregulation and mental health problems later in life (Panksepp & Biven, 2012).

Moreover, Panksepp’s research highlights the role of genetics in emotional processing and regulation, with certain genetic variations associated with increased vulnerability to anxiety, depression, and other mood disorders (Panksepp, 2007). Panksepp’s work has also emphasised the importance of understanding the interplay between environmental and genetic factors in shaping emotional functioning and mental health outcomes.

Panksepp’s work underscores the need for early intervention and prevention strategies that address both environmental and genetic risk factors for emotional dysregulation and mental health disorders. By promoting healthy emotional development and addressing emotional dysregulation early on, it may be possible to mitigate the negative impact of early life experiences and genetic vulnerabilities on mental health outcomes.

(Please see Panksepp, J. (2007). Neuroevolutionary sources of laughter and social joy: Modeling primal human laughter in laboratory rats. Behavioural Brain Research, 182(2), 231-244. 

Panksepp, J., & Biven, L. (2012). The archaeology of mind: Neuroevolutionary origins of human emotions. WW Norton & Company.)

IV. Affective Neuroscience and Clinical Applications

Affective neuroscience research has significantly contributed to understanding emotions and their underlying neural mechanisms. These findings have also provided valuable insights into developing and treating emotional disorders, such as anxiety and depression.

A critical aspect of affective neuroscience research is the identification of specific neural circuits involved in emotion processing, regulation, and expression. This knowledge has led to the development of novel therapeutic approaches, such as neurofeedback training, which targets specific brain regions to enhance emotion regulation.

Another critical application of affective neuroscience research is the development of pharmacological interventions that target specific neurotransmitter systems implicated in emotional disorders. For example, selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat depression and anxiety by increasing serotonin levels in the brain.

Affective neuroscience research has also informed the development of psychotherapeutic approaches focusing on emotional regulation and processing, such as mentalisation-based therapy (MBT) and mindfulness-based interventions. These approaches aim to help individuals develop more adaptive emotion regulation strategies and increase emotional awareness.

Integrating affective neuroscience research into clinical practice can improve the effectiveness and specificity of treatments for emotional disorders, ultimately leading to better outcomes for patients.

Panksepp’s contributions to affective neuroscience have greatly informed psychotherapy and clinical interventions for emotional disorders. Panksepp’s work on the brain’s emotional systems has been particularly influential in understanding the underlying mechanisms of affective disorders such as depression, anxiety, and borderline personality disorder. One of the main implications of his research is the importance of understanding early-life experiences, particularly attachment and bonding, in shaping emotional regulation abilities and vulnerability to emotional disorders.

Panksepp’s findings on the neural basis of emotional systems have also been used to develop novel therapeutic interventions. For instance, his research on the opioid system’s role in social bonding has led to the development of attachment-based therapies. Similarly, his work on the mesolimbic dopamine system’s role in reward processing has informed the development of reward-based treatments for depression and addiction.

In addition to Panksepp’s contributions, other researchers in affective neuroscience have also informed clinical practice. For instance, the research on cognitive reappraisal has led to the development of cognitive-behavioural therapy (CBT), which focuses on changing negative thoughts and behaviours to alleviate emotional distress. Furthermore, advances in neuroimaging techniques have allowed for a better understanding of the underlying neural mechanisms of emotional disorders, which has led to the development of more targeted and effective treatments.

Panksepp’s work and other findings in affective neuroscience have greatly enhanced our understanding of emotional disorders and informed the development of novel and effective clinical interventions.

Neurofeedback, psychopharmacology, and other neuroscience-informed interventions have become increasingly popular in treating mental health disorders. These interventions aim to modify brain activity and neurochemical processes to improve emotional regulation and alleviate symptoms of psychiatric disorders.

Neurofeedback involves giving patients real-time feedback on their brain activity, allowing them to learn to regulate their brain function. This technique has been used to treat various psychiatric disorders, including anxiety, depression, and attention deficit/hyperactivity disorder (ADHD). Studies have shown that neurofeedback can improve symptoms and may be as effective as traditional psychotherapy or medication (Hammond, 2011).

Psychopharmacology involves the use of medications to modify neurochemical processes in the brain. Drugs targeting neurotransmitter systems such as serotonin, dopamine, and norepinephrine are commonly used to treat mood disorders such as depression and anxiety. However, these medications can have side effects and may not be effective for all patients. Additionally, medication alone may not address the underlying emotional and psychological issues contributing to a disorder.

Other neuroscience-informed interventions include transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS). These techniques involve electrical or magnetic stimulation to modulate brain activity and have shown promise in treating depression and other psychiatric disorders (George et al., 2013; Lisanby, 2012; Riva-Posse et al., 2014).

While these interventions offer promising avenues for treatment, it is consequential to note that they are still in the early stages of development and may not be suitable for all patients or disorders. Additionally, these interventions should be used in conjunction with other therapies, such as psychotherapy or cognitive-behavioural therapy (CBT), to address the emotional and psychological issues underlying the disorder.

In conclusion, neurofeedback, psychopharmacology, and other neuroscience-informed interventions offer new avenues for treating mental health disorders. These interventions can modify brain activity and neurochemical processes to improve emotional regulation and alleviate symptoms. However, they should be complementary to other therapies, and caution should be exercised. Further research, as ever, is needed to understand their efficacy and long-term effects.

(Please see George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlova, M., … & Sackeim, H. A. (2013). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomised trial. Archives of general psychiatry, 70(1), 27-38.

Hammond, D. C. (2011). What is neurofeedback? Journal of Neurotherapy, 15(4), 305-336.

Lisanby, S. H. (2012). Electroconvulsive therapy for depression. New England Journal of Medicine, 366(18), 1778-1787.

and also Riva-Posse, P., Choi, K. S., Holtzheimer III, P. E., Crowell, A. L., Garlow, S. J., Rajendra, J. K., … & Mayberg, H. S. (2014). A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Molecular psychiatry, 19(9), 1049-1052.)

Utilising affective neuroscience in clinical practice raises noteworthy ethical considerations and limitations. One ethical concern is the potential for stigmatisation and labelling of individuals based on their neurological profiles or biomarkers. This stigma may lead to discrimination and further marginalisation of specific individuals, particularly those with mental health disorders. 

Using neuroimaging techniques, such as functional magnetic resonance imaging (fMRI), raises issues regarding the accuracy and interpretation of the results and concerns about the potential for false positives and negatives. The use of psychopharmacology and other interventions based on affective neuroscience research also raises concerns about the potential for over-medicalisation and the prioritisation of biological explanations over psychological and social factors.

Similarly, there are limitations to using affective neuroscience in clinical practice. The complex and dynamic nature of emotions and their regulation means it is challenging to capture and understand the underlying neural mechanisms fully. Additionally, there is significant individual variability in the neural processes involved in emotion regulation, and it is unclear whether neuroscientific findings can be generalised to all individuals. Moreover, the use of affective neuroscience in clinical practice requires specialised training and resources, which may limit its accessibility and availability to specific populations.

While affective neuroscience has the potential to inform and improve clinical practice, it is crucial to carefully consider its ethical implications and limitations. By taking a balanced and integrated approach that considers biological, psychological, and social factors, clinicians can provide more effective and holistic care for individuals with mental health disorders.

V. Reflections in conclusion

Panksepp’s work in affective neuroscience has contributed dramatically to our understanding of the neural mechanisms underlying emotional processes and their role in mental health and well-being. His research has shown that emotions are not merely subjective experiences with important physiological and neurobiological components. He proposed the idea of basic emotional systems, which are hard-wired in the brain and can be found in many different animal species.

Panksepp’s work spotlights the importance of early life experiences, trauma, and genetics in shaping emotion regulation abilities and vulnerabilities to mental health disorders. 

Emotional dysregulation has been extensively studied in affective neuroscience and linked to a wide range of mental health issues, including common anxiety, depression, and less common borderline personality disorder.

Findings from affective neuroscience research have informed psychotherapy and clinical interventions for emotional disorders. Techniques such as attachment-based therapies, mentalisation-based therapies, mindfulness-based interventions, cognitive-behavioural therapy and neurofeedback have been developed based on understanding the neurobiological mechanisms of emotional processes. These approaches aim to improve emotional regulation and reduce the risk of mental health disorders.

Panksepp’s work and other findings in affective neuroscience have significantly advanced our understanding of emotions and their role in mental health. Future research in this field has the potential to continue to inform and improve clinical practice, ultimately leading to better mental health outcomes for individuals.

Understanding the neurobiological basis of emotions has significant implications for future research and clinical practice. As our knowledge of the neural mechanisms involved in emotion processing and regulation expands, new therapeutic interventions and treatments will likely be developed targeted explicitly to the neural circuitry involved in emotional disorders. For example, researchers may develop more precise neurofeedback techniques that directly target specific neural circuits associated with emotion regulation.

Future research could examine individual differences in emotional processing and regulation, which could help inform personalised treatment approaches considering a patient’s unique neurobiological profile. This may involve developing more sophisticated brain imaging techniques to provide more detailed information about the functional connectivity and activity within specific brain regions.

There is, of course, a need for further research and funding into both the environmental and genetic factors contributing to emotional disorders’ development and treatment. Researchers can develop more effective prevention and early intervention strategies by identifying the specific genes and environmental factors that increase vulnerability to emotional disorders. As deeper understandings of the neurobiological and neuropsychological bases of emotions emerge, they will, no doubt, revolutionise the current mental health paradigm and lead to ever-more effective and personalised treatments for emotional disorders.

Bibliography

Bateman, A.W., & Fonagy, P. (2004). Psychotherapy for Borderline Personality Disorder: Mentalization-Based Treatment. Oxford University Press. Barrett, L. F. (2017). The theory of constructed emotion: An active inference account of interoception and categorisation. Social Cognitive and Affective Neuroscience, 12(1), 1-23.

Davidson, R. J., & Irwin, W. (Eds.). (2003). The neuropsychology of emotion. Oxford University Press.

George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlova, M., … & Sackeim, H. A. (2013). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomised trial. Archives of general psychiatry, 70(1), 27-38.

Hammond, D. C. (2011). What is neurofeedback? Journal of Neurotherapy, 15(4), 305-336.

Lisanby, S. H. (2012). Electroconvulsive therapy for depression. New England Journal of Medicine, 366(18), 1778-1787.

Panksepp, J. (1998). Affective neuroscience: The foundations of human and animal emotions. Oxford University Press.

Panksepp, J. (2007). Neuroevolutionary sources of laughter and social joy: Modeling primal human laughter in laboratory rats. Behavioural Brain Research, 182(2), 231-244.

Panksepp, J., & Biven, L. (2012). The archaeology of mind: Neuroevolutionary origins of human emotions. WW Norton & Company.

Phelps, E. A. (2006). Emotion and cognition: Insights from studies of the human amygdala. Annual Review of Psychology, 57, 27-53. Porges SW (2021). Polyvagal Safety: Attachment, Communication and Self-Regulation. New York: WW Norton. ​ Porges SW & Dana D (2018).  Clinical Applications of the Polyvagal Theory: The Emergence of Polyvagal-Informed Therapies. New York: WW Norton.

Riva-Posse, P., Choi, K. S., Holtzheimer III, P. E., Crowell, A. L., Garlow, S. J., Rajendra, J. K., … & Mayberg, H. S. (2014). A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Molecular psychiatry, 19(9), 1049-1052.

Salzman, C. D., & Fusi, S. (2010). Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annual Review of Neuroscience, 33, 173-202.

Solms, M. (1997). What is consciousness?. Journal of consciousness studies, 4(4), 375-398.

Solms, M. (2004). Freud returns. International journal of psychoanalysis, 85(3), 537-549.

Solms, M. (2013). The feeling brain: Selected papers on neuropsychoanalysis. Karnac Books.

Solms, M. (2019). The Hidden Spring: A Journey to the Source of Consciousness. WW Norton & Company.

Solms, M., & Turnbull, O. (2002). The brain and the inner world: An introduction to the neuroscience of subjective experience. Karnac Books.